Takeda Pharmaceutical Company Limited (TAK)
NYSE: TAK · Real-Time Price · USD
16.41
+0.05 (0.31%)
Apr 28, 2026, 4:00 PM EDT - Market closed
Takeda Pharmaceutical Market Cap
Takeda Pharmaceutical has a market cap or net worth of $52.36 billion as of April 28, 2026. Its market cap has increased by 19.07% in one year.
Market Cap
52.36B
Enterprise Value
82.24B
1-Year Change
19.07%
Ranking
Category
Stock Price
$16.41
Market Cap Chart
Since January 5, 2010, Takeda Pharmaceutical's market cap has decreased from $71.21B to $52.36B, a decrease of -26.47%. That is a compound annual growth rate of -1.87%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Apr 27, 2026 | 51.68B | 6.12% |
| Dec 31, 2025 | 48.70B | 15.61% |
| Dec 31, 2024 | 42.13B | -5.91% |
| Dec 29, 2023 | 44.78B | -7.43% |
| Dec 30, 2022 | 48.37B | 13.50% |
| Dec 31, 2021 | 42.62B | -24.84% |
| Dec 31, 2020 | 56.70B | -8.18% |
| Dec 31, 2019 | 61.76B | 134.31% |
| Dec 31, 2018 | 26.36B | -59.21% |
| Dec 30, 2016 | 64.61B | -22.54% |
| Dec 31, 2015 | 83.40B | 20.68% |
| Dec 31, 2014 | 69.11B | -9.90% |
| Dec 31, 2013 | 76.71B | 3.69% |
| Dec 31, 2012 | 73.97B | 0.68% |
| Dec 30, 2011 | 73.47B | -9.45% |
| Dec 31, 2010 | 81.14B | 13.94% |
View and export this data all the way back to 2010.
Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Zoetis | 49.05B |
| Haleon | 42.16B |
| Teva Pharmaceutical Industries | 36.82B |
| United Therapeutics | 24.94B |
| Viatris | 17.26B |
| Regencell Bioscience Holdings | 14.36B |
| Neurocrine Biosciences | 12.89B |
| Dr. Reddy's Laboratories | 11.92B |